Brendan Smith - Chief Financial Officer at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brendan Smith since 9/18/2023

Holdings reported by Brendan Smith for CRISPR Therapeutics AG

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 5.07K $317K $62.50 Feb 21, 2023 Direct
Stock Option (Right to Buy) 14K Oct 7, 2022 Direct Common Shares
Restricted Stock Units 11.5K Feb 18, 2023 Direct Common Shares

Transactions reported by Brendan Smith for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.